Véronique Blouin

1.9k total citations
37 papers, 1.3k citations indexed

About

Véronique Blouin is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Véronique Blouin has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 29 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Véronique Blouin's work include Virus-based gene therapy research (30 papers), Viral Infectious Diseases and Gene Expression in Insects (13 papers) and CRISPR and Genetic Engineering (12 papers). Véronique Blouin is often cited by papers focused on Virus-based gene therapy research (30 papers), Viral Infectious Diseases and Gene Expression in Insects (13 papers) and CRISPR and Genetic Engineering (12 papers). Véronique Blouin collaborates with scholars based in France, United States and United Kingdom. Véronique Blouin's co-authors include Philippe Moullier, Anna Salvetti, Richard O. Snyder, Yan Chérel, Magalie Penaud‐Budloo, David Favre, Eduard Ayuso, Mavis Agbandje‐McKenna, Kim Van Vliet and N Provost and has published in prestigious journals such as Journal of Virology, Scientific Reports and Chemical Science.

In The Last Decade

Véronique Blouin

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Blouin France 22 1.0k 993 190 161 115 37 1.3k
Scott Loiler United States 13 722 0.7× 781 0.8× 140 0.7× 130 0.8× 135 1.2× 20 1.2k
Guang Qu United States 12 892 0.9× 849 0.9× 198 1.0× 134 0.8× 129 1.1× 18 1.1k
Magalie Penaud‐Budloo France 15 829 0.8× 804 0.8× 144 0.8× 149 0.9× 120 1.0× 24 1.0k
Marie Montus France 8 837 0.8× 662 0.7× 212 1.1× 89 0.6× 189 1.6× 10 1.1k
Oumeya Adjali France 18 759 0.7× 581 0.6× 192 1.0× 58 0.4× 97 0.8× 53 1.1k
Margaret Humphries United States 10 893 0.9× 863 0.9× 286 1.5× 156 1.0× 155 1.3× 15 1.3k
Caroline Le Guiner France 20 1.3k 1.3× 657 0.7× 119 0.6× 68 0.4× 158 1.4× 47 1.6k
Hervé Conrath France 4 716 0.7× 691 0.7× 96 0.5× 71 0.4× 98 0.9× 4 890
Baozheng Li United States 16 1.3k 1.2× 1.2k 1.2× 167 0.9× 287 1.8× 149 1.3× 24 1.7k
Melissa A. Kotterman United States 5 935 0.9× 607 0.6× 119 0.6× 54 0.3× 89 0.8× 9 1.1k

Countries citing papers authored by Véronique Blouin

Since Specialization
Citations

This map shows the geographic impact of Véronique Blouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Blouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Blouin more than expected).

Fields of papers citing papers by Véronique Blouin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Blouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Blouin. The network helps show where Véronique Blouin may publish in the future.

Co-authorship network of co-authors of Véronique Blouin

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Blouin. A scholar is included among the top collaborators of Véronique Blouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Blouin. Véronique Blouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chali, Farah, Véronique Blouin, Wilfred F.A. den Dunnen, et al.. (2025). Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease. Acta Neuropathologica Communications. 13(1). 184–184.
2.
Saleün, Sylvie, Caroline Mas, Aline Le Roy, et al.. (2023). Analytical ultracentrifugation sedimentation velocity for the characterization of recombinant adeno-associated virus vectors sub-populations. European Biophysics Journal. 52(4-5). 367–377. 8 indexed citations
3.
Gautier, Benoît, et al.. (2022). AAV2/9-mediated gene transfer into murine lacrimal gland leads to a long-term targeted tear film modification. Molecular Therapy — Methods & Clinical Development. 27. 1–16. 4 indexed citations
4.
Saleün, Sylvie, Suk Namkung, Kristina Weber, et al.. (2022). Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity. Human Gene Therapy. 33(7-8). 371–388. 50 indexed citations
5.
Saleün, Sylvie, et al.. (2020). The SSV‐Seq 2.0 PCR‐Free Method Improves the Sequencing of Adeno‐Associated Viral Vector Genomes Containing GC‐Rich Regions and Homopolymers. Biotechnology Journal. 16(1). e2000016–e2000016. 9 indexed citations
6.
François, Achille, Mohammed Bouzelha, Magalie Penaud‐Budloo, et al.. (2018). Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls. Molecular Therapy — Methods & Clinical Development. 10. 223–236. 40 indexed citations
7.
Penaud‐Budloo, Magalie, Sylvie Saleün, Alain Roulet, et al.. (2017). Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells. Human Gene Therapy Methods. 28(3). 148–162. 37 indexed citations
8.
Santos, Christine Dos, et al.. (2017). An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21−/− mouse model. Gene Therapy. 24(5). 275–281. 25 indexed citations
9.
Ciron, Carine, Laurence Dubreil, Johan Deniaud, et al.. (2017). Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders. Gene Therapy. 24(5). 325–332. 59 indexed citations
10.
Tshilenge, Kizito‐Tshitoko, Baptiste Ameline, Michel Weber, et al.. (2016). Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates. Human Gene Therapy Methods. 27(3). 122–134. 28 indexed citations
11.
Dollet, Lucile, Jocelyne Magré, Cédric Le May, et al.. (2016). Seipin deficiency alters brown adipose tissue thermogenesis and insulin sensitivity in a non-cell autonomous mode. Scientific Reports. 6(1). 35487–35487. 16 indexed citations
12.
Guan, Xuan, Zejing Wang, Stefan Czerniecki, et al.. (2015). Use of Adeno-Associated Virus to Enrich Cardiomyocytes Derived from Human Stem Cells. PubMed. 26(3). 194–201. 7 indexed citations
13.
Cogné, Benjamin, Pierre Lindenbaum, Matthias Hebben, et al.. (2015). Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing. Molecular Therapy — Nucleic Acids. 4. e260–e260. 62 indexed citations
14.
Sudres, Muriel, Virginie Vasseur, L. Brault, et al.. (2012). MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAV. Molecular Therapy. 20(8). 1571–1581. 48 indexed citations
15.
Wang, Lijun, et al.. (2011). Production and Purification of Recombinant Adeno-Associated Vectors. Methods in molecular biology. 807. 361–404. 20 indexed citations
16.
Vliet, Kim Van, Scott McClung, Véronique Blouin, et al.. (2009). Adeno-associated virus capsid serotype identification: Analytical methods development and application. Journal of Virological Methods. 159(2). 167–177. 25 indexed citations
17.
Vliet, Kim Van, et al.. (2008). The Role of the Adeno-Associated Virus Capsid in Gene Transfer. Methods in molecular biology. 437. 51–91. 86 indexed citations
18.
Vliet, Kim Van, Véronique Blouin, Mavis Agbandje‐McKenna, & Richard O. Snyder. (2006). Proteolytic Mapping of the Adeno-associated Virus Capsid. Molecular Therapy. 14(6). 809–821. 23 indexed citations
19.
Blouin, Véronique, et al.. (2004). Improving rAAV production and purification: towards the definition of a scaleable process. The Journal of Gene Medicine. 6(S1). S223–S228. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Loiler Breakdown of academic impact, for papers by Guang Qu Breakdown of academic impact, for papers by Magalie Penaud‐Budloo Breakdown of academic impact, for papers by Marie Montus Breakdown of academic impact, for papers by Oumeya Adjali Breakdown of academic impact, for papers by Margaret Humphries Breakdown of academic impact, for papers by Caroline Le Guiner Breakdown of academic impact, for papers by Hervé Conrath Breakdown of academic impact, for papers by Baozheng Li Breakdown of academic impact, for papers by Melissa A. Kotterman
Rankless by CCL
2026